| Aug 5 |
Summit Therapeutics Q2 2024 Earnings Preview
|
| Aug 3 |
Summit Therapeutics May Have Further Upside From Here
|
| Jul 29 |
Summit Therapeutics to Host Second Quarter 2024 Financial Results & Operational Progress Call on August 6, 2024
|
| Jul 25 |
Summit Therapeutics and MD Anderson Announce Strategic Collaboration to Accelerate Development of Ivonescimab
|
| Jul 22 |
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
|
| Jul 14 |
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
|
| Jun 27 |
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
|
| Jun 17 |
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
|
| Jun 12 |
Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
|
| Jun 8 |
AstraZeneca dominates, Merck’s Keytruda beaten as ASCO 2024 concludes
|
